| Identification | |
| Name: | Gemifloxacin |
| Synonyms: | 7-[(4Z)-3-(Aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid;1,8-naphthyridine-3-carboxylic acid, 7-[(4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-;(Z)-7-(3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; |
| CAS: | 175463-14-6 |
| Molecular Formula: | C18H20FN5O4 |
| Molecular Weight: | 389.39 |
| InChI: | InChI=1/C18H20FN5O4/c1-28-22-14-8-23(6-9(14)5-20)17-13(19)4-11-15(25)12(18(26)27)7-24(10-2-3-10)16(11)21-17/h4,7,9-10H,2-3,5-6,8,20H2,1H3,(H,26,27)/b22-14+ |
| Molecular Structure: | ![(C18H20FN5O4) 7-[(4Z)-3-(Aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,...](https://img.guidechem.com/casimg/175463-14-6.gif) |
| Properties | |
| Density: | 1.64g/cm3 |
| Refractive index: | 1.735 |
| Appearance: | powder |
| Specification: |
Gemifloxacin (CAS NO.175463-14-6) is an oral broad-spectrum quinolone antibacterial agent which is used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia. |
| Safety Data | |
 |
|
